Gene therapy in the treatment of intestinal inflammation
โ Scribed by Catherine Montfrans; AnjeA. Velde; SanderJ.H. Deventer; MariaSol Rodriguez Pena
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 261 KB
- Volume
- 19
- Category
- Article
- ISSN
- 0179-1958
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Background: We developed a series of dendritic cell autoimmune modulators (DCAMs) based on small molecule Flt3 receptor tyrosine kinase inhibitors (TKIs) for the inhibition of intestinal inflammation and oral delivery. Methods: DCAMs were administered orally during and after induction of dextr
he in vivo local delivery of regulatory cytokines made possible by gene therapy is becoming an exciting approach for treating common disorders such as cancer and viral infections I. Recently, gene therapy strategies have been applied to the treatment of autoimmune diseases. Cells targeted for autoim